For the year ending 2025-12-31, NVCT has $31,709K in assets. $13,296K in debts. $31,634K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 31,634 | |||
| Other current assets | 75 | |||
| Total current assets | 31,709 | |||
| Total assets | 31,709 | |||
| Accounts payables | 6,274 | |||
| Accrued liabilities | 115 | |||
| Employee compensation and benefits | 6,907 | |||
| Total current liabilities | 13,296 | |||
| Total liabilities | 13,296 | |||
| Additional paid in capital | 118,100 | |||
| Accumulated deficit | -99,687 | |||
| Total shareholders' equity | 18,413 | |||
| Total liabilities and shareholders' equity | 31,709 | |||
Nuvectis Pharma, Inc. (NVCT)
Nuvectis Pharma, Inc. (NVCT)